The new Canadian cardiovascular society algorithm for antithrombotic therapy of atrial fibrillation is appropriately based on current epidemiologic data

Canadian Journal of Cardiology

Volumn 31, Issue 1, 2015, Pages 20-23

  Cairns, John A ^a   Healey, Jeff S ^b   Macle, Laurent ^c   Mitchell, L Brent ^d,e   Verma, Atul ^f  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c MONTREAL HEART INSTITUTE   (Canada)

^d UNIVERSITY OF CALGARY   (Canada)

^e ALBERTA HEALTH SERVICES   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CLOPIDOGREL; WARFARIN;

ANTICOAGULANT THERAPY; BLOOD PRESSURE; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLASSIFICATION ALGORITHM; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; EDITORIAL; EPIDEMIOLOGICAL DATA; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; HYPERTENSION; MEDICAL SOCIETY; PRACTICE GUIDELINE; RISK ASSESSMENT; THROMBOEMBOLISM; TRANSIENT ISCHEMIC ATTACK; VASCULAR DISEASE; ALGORITHM; ATRIAL FIBRILLATION; FEMALE; MALE; PROCEDURES;

ALGORITHMS; ANTICOAGULANTS; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; FEMALE; HUMANS; MALE; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; SOCIETIES, MEDICAL;

EID: 84920455127     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2014.11.021     Document Type: Editorial

References (16)

1. Lip Y.H., Nielsen P.B., Skjoth F., Rasmussen L.H., Larsen T.B. Atrial fibrillation patients categorized as "not for anticoagulation" according to the 2014 Canadian Cardiovascular Society algorithm are not "low risk.". Can J Cardiol 2015, 31:24-28.
2. Verma A., Cairns J.A., Mitchell B., et al. 2014 Focused update of the Canadian Cardiovascular Society guidelines for the management of atrial fibrillation. Can J Cardiol 2014, 30:1114-1130.
3. Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators. Ann Intern Med 1992, 116:1-5.
4. Risk factors for stroke and efficiency of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994, 154:1449-1457.
5. Gage B.F., Waterman A.D., Shannon, et al. Validation of clinical classification schemes for predicting stroke. Results from the National Registry of Atrial Fibrillation. JAMA 2001, 285:2864-2870.
6. Lip G.Y., Nieuwlaat R., Pisters R., Lane D.R., Crijns H.J. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation. Chest 2010, 137:263-272.
7. Lip G.Y., Frison L., Halperin J.L., Lane D.A. Identifying patients at high risk for stroke despite anticoagulation. A comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation cohort. Stroke 2010, 41:2731-2738.
8. Camm A.J., Kirchof P., Lip G.Y., et al. Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Guidelines for the management of atrial fibrillation. Eur Heart J 2010, 31:2369-2429.
9. Camm A.J., Lip G.Y., De Caterina R., et al. 2012 Focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 2012, 33:2719-2747.
10. Lip G.Y. Stroke in atrial fibrillation: epidemiology and thromboprophylaxis. JThromb Haemost 2011, 9(suppl 1):344-351.
11. Cairns J.A., Connolly S., McMurtry S., et al. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter. Can J Cardiol 2011, 27:74-90.
12. Olesen J.B., Lip G.Y., Hansen M.L., et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ 2011, 342:d124.
13. Skanes A.C., Healey J.S., Cairns J.A., et al. Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control. Can J Cardiol 2012, 28:125-136.
14. Olesen J.B., Lip G.Y., Lane D.A., et al. Vascular disease and stroke risk in atrial fibrillation: a nationwide cohort study. Am J Med 2012, 125:826.e13-826.e23.
15. Friberg L., Rosenqvist M., Lip G.Y. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation Cohort study. Eur Heart J 2012, 33:1500-1510.
16. Mikkelsen A.P., Lindharden J., Lip G.Y., Gislason G.H., Torp-Pedersen C. Female sex as a risk factor for stroke in atrial fibrillation: a nationwide cohort study. JThromb Haemost 2012, 10:1745-1751.